Wang et al. 71 demonstrated that NAT10 participates in the ac4C modification of B-cell CLL/lymphoma 9-like (BCL9L), SRY-related HMG-box 4 (SOX4), and serine/threonine-protein kinase (AKT1) mRNAs in BC cells, enhancing their stability and translation efficiency through wobble position acetylation. Here, BCL9L is linked to breast cancer.